Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T23:02:03.445Z Has data issue: false hasContentIssue false
  • English
  • Français

Vaccine-Induced Myocarditis in Two Intern Doctors in the Same Night Shift

Published online by Cambridge University Press:  19 July 2022

Mustafa Emin Canakci Open the ORCID record for Mustafa Emin Canakci [Opens in a new window] ,
Omer Erdem Sevik ,
Gokhan Dereli ,
Kadir Ugur Mert  and
Nurdan Acar
Mustafa Emin Canakci*
Affiliation:
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Omer Erdem Sevik
Affiliation:
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Gokhan Dereli
Affiliation:
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Kadir Ugur Mert
Affiliation:
Cardiology Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Nurdan Acar
Affiliation:
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
*
Correspondence: Mustafa Emin Canakci, MD Emergency Department Eskisehir Osmangazi University School of MedicineEskisehir, Turkey Prof. Dr. Nabi Avcı Boulevard, No:4, Meselik, Odunpazarı, 26040 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the globe and vaccines against the disease have started to develop. Side effects of the vaccine have been reported in the literature, including myocarditis, which has a very low incidence and with a good prognosis. This case report aims to present two medical students’ vaccine-induced myocarditis cases after the first doses of BNT162b2.

These patients were young males with no previous medical history and both of them had good recovery after the disease. Both of them had their vaccine very recently before the event. These cases show that myocarditis can be seen after the first dose as well.

Global vaccination is the most effective prevention method against COVID-19. Considering the fact that morbidities after the disease occur more than the side effects of the vaccine, they are still the best option against the current pandemic.

Keywords

COVID-19mRNAmyocarditisvaccine
Type
Case Report
Information
Prehospital and Disaster Medicine , Volume 37 , Issue 5 , October 2022 , pp. 698 - 700
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the World Association for Disaster and Emergency Medicine

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine. Accessed April 23, 2022.Google Scholar
Mevorach, D, Anis, E, Cedar, N, et al. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel. N Engl J Med. 2021;385(23):2140–2149.CrossRefGoogle ScholarPubMed
Meo, SA, Bukhari, IA, Akram, J, Meo, AS, Klonoff, DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663–1669.Google ScholarPubMed
Witberg, G, Barda, N, Hoss, S, et al. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med. 2021;385(23):2132–2139.CrossRefGoogle Scholar
Li, C, Chen, Y, Zhao, Y, et al. Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis. 2022;74(11):1933–1950.CrossRefGoogle ScholarPubMed
Ling, RR, Ramanathan, K, Tan, FL, et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(7):679–688.CrossRefGoogle ScholarPubMed